Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Leica Microsystems, CMED Collaborate on FISH Kits

Photonics.com
Aug 2011
BEIJING & WETZLAR, Germany, Aug. 12, 2011 — In vitro diagnostic company China Medical Technologies Inc. (CMED) and Leica Biosystems, a division of Leica Microsystems, have established a sales, research and development collaboration to develop and market FISH kits for the Leica Bond system, an automated staining platform.

The two companies will develop automated solutions for tissue sample tests on HER-2, EGFR and TOP2A genes, all three of which play a role in targeted drug therapy for breast, lung and stomach cancer patients.

Both parties have agreed to work together on additional FISH applications during the term, including those relevant to prenatal care and cytology.

In addition, they have agreed that CMED will sell the FISH kits in China, while Leica will have the option to sell them in the rest of the world.

Leica Microsystems develops microscopes and scientific instruments. Its Biosystems Div. offers products for histopathology laboratories.

For more information, visit: www.leica-microsystems.com  


Asia-Pacificautomated FISH kitsBiophotonicsbreast cancer drug therapyBusinesscancer therapy drugsChinaChina Medical Technologies Inc.CMEDcytologyEGFR geneEuropeFISH kitsGermanyHER-2 genehistopathologyimagingin vitro diagnosticsLeica BiosystemsLeica BONDLeica Microsystemslung cancer drug therapymicroscopesMicroscopyprenatal applicationsstaining platformstomach cancer drug therapytissue sample testsTOP2A gene

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.